[Responder and non-responder in the bronchodilator test?]
- PMID: 8584530
[Responder and non-responder in the bronchodilator test?]
Abstract
In 15 patients with chronic airflow obstruction 0.2 mg salbutamol was administered to determine reversibility within 15 minutes ("test effect"). Subsequently, maximum 24-hour effects of three beta 2-agonists (fenoterol 0.2 mg, salbutamol 0.2 mg, salmeterol 0.05 mg, each by MDI) were determined in random order ("best effect"). Airways obstruction was measured by FEV1, MEF50, MEF25, airway resistance Raw and thoracic gas volume TGV. "Best effects" were compared with "test effects". As a whole test effects were significantly smaller than best effects, often not reaching a 15% change, normally achieved during the 24-hour observation. Significant correlations existed between FEV1 and the corresponding values of Raw, MEF50 and MEF25, although there were considerable individual differences between test results. The reduction of TGV after a beta 2-agonist was significantly related to TGV-baseline values. We conclude in line with other authors that tests of acute reversibility of airways obstruction cannot reliably differentiate between "responders" and "non-responders" and that such tests may mislead if used for the differentiation of asthma and COPD.
Similar articles
-
[Effect duration and treatment effectiveness of salmeterol, fenoterol and salbutamol in severe forms of respiratory tract obstruction].Pneumologie. 1995 Oct;49(10):528-34. Pneumologie. 1995. PMID: 8584522 Clinical Trial. German.
-
[The effect of salmeterol in the treatment of smokers with chronic obstructive lung disease].Ugeskr Laeger. 1996 Jun 17;158(25):3604-7. Ugeskr Laeger. 1996. PMID: 8693619 Clinical Trial. Danish.
-
A comparison of the bronchodilator effects of broxaterol and salbutamol.Int J Clin Pharmacol Ther Toxicol. 1988 Feb;26(2):93-7. Int J Clin Pharmacol Ther Toxicol. 1988. PMID: 2900816 Clinical Trial.
-
Response to bronchodilators.Clin Chest Med. 1989 Jun;10(2):155-64. Clin Chest Med. 1989. PMID: 2567648 Review.
-
Assessment of reversibility in patients with chronic airflow obstruction.Br J Clin Pract. 1992 Summer;46(2):132-5. Br J Clin Pract. 1992. PMID: 1457301 Review.
Cited by
-
Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2006 Jul 19;2006(3):CD001104. doi: 10.1002/14651858.CD001104.pub2. Cochrane Database Syst Rev. 2006. PMID: 16855959 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials